Structure

    PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,Und,H,0,PA

Occurrence of a D-arabinose-containing complex-type free-N-glycan in the urine of cancer patients

GlyTouCan Accession Number: Loading...

Peak Intensity
366.17 1.6

Annotations:

BY a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,Und,H,0,PA CZ a1D-Man,p/#ccleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,Und,H,0,PA
366.43 1.0

Annotations:

BY a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,Und,H,0,PA CZ a1D-Man,p/#ccleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,Und,H,0,PA
368.37 0.4
378.43 0.4
413.98 0.5
414.37 0.5
426.17 0.8
427.4 0.5
432.31 7.1
433.52 0.5
444.27 33.8

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p/#zcleavage$MONO,Und,H,0,PA
445.28 3.4
462.29 153.2

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p/#ycleavage$MONO,Und,H,0,PA
463.31 28.2
498.33 1.0

Annotations:

CZ b1D-Man,p/#ccleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA B a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,Und,H,0,PA BY b1D-Man,p/#bcleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
504.36 1.0
528.44 0.5

Annotations:

BY b1D-Man,p/#bcleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,Und,H,0,PA CZ b1D-Man,p/#ccleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,Und,H,0,PA
576.39 3.2
577.03 0.7
577.35 1.3
588.28 0.6
594.34 20.8
595.53 3.3
604.38 1.9
605.47 0.8

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#zcleavage$MONO,Und,H,0,PA
606.4 43.7

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#zcleavage$MONO,Und,H,0,PA
607.41 5.9
622.53 1.6
624.38 419.7

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#ycleavage$MONO,Und,H,0,PA
625.34 96.1
732.38 0.4
737.48 0.6
738.42 6.3
739.26 0.5
739.63 0.6
756.42 72.7
757.43 20.7
786.47 3.0
787.51 0.4
791.68 0.4

Annotations:

ZZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA
809.22 0.5

Annotations:

YZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA ZY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
809.51 1.0

Annotations:

YZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA ZY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
809.74 0.4

Annotations:

YZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA ZY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
810.22 0.6

Annotations:

YZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA ZY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
810.59 0.6
827.47 16.3

Annotations:

YY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
828.44 4.4
828.76 0.9
839.48 0.8

Annotations:

C ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,Und,H,0,PA
918.64 0.4
922.79 0.5
923.34 0.4
941.48 3.3

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#zcleavage$MONO,Und,H,0,PA
942.49 0.7
956.7 0.4
958.56 0.7

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
959.53 37.8

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#ycleavage$MONO,Und,H,0,PA
960.53 12.8
971.54 13.0

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,Und,H,0,PA
972.41 4.1
972.84 2.1
976.62 0.8
987.28 1.3
987.52 0.9
989.51 245.6

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,Und,H,0,PA
990.52 93.9
1018.62 0.5
1019.53 0.5
1027.51 0.6
1032.6 0.5
1036.99 0.4
1038.11 0.4
1038.51 1.7
1039.02 0.5
1039.74 0.5
1040.55 0.4
1041.08 0.5
1057.81 0.5
1059.81 1.5
1060.38 0.8
1061.06 0.8
1063.75 0.4
1077.19 0.8
1078.16 0.7
1081.17 0.9
1083.44 0.8
1088.75 0.4
1089.67 0.4
1090.02 0.6
1090.34 0.9
1090.66 1.2
1097.73 0.6
1101.07 0.7
1101.51 4.1
1101.79 3.1
1102.66 4.6
1103.59 110.0
1104.76 27.4
1110.23 0.7
1114.7 0.7

There are not related spectra

Structure Format

SNFG Oxford Text

Structure details

Reducing Mass: 1118.43
(Calculated Monoisotopic)

Reducing End: 2-Aminopyridine

Persubstitution: Underivatised

Biological Context

Taxonomy - Homo Sapiens
Tissue - Urine

HPLC

Column

Method

  • 14min gradient with 0.05ml/min run rate
  • 5mM Acetic acid/Triethylamine (pH6.0)
  • 50% acetonitrile

Mass Spec

Thermo Fisher LTQ Linear Ion Trap ESI

Report errors in this entry

UniCarb-DR Creative Commons License

Supported by SIB ExPASy  |  JST / NBDCDICP